Home > Insider Trading > Filing (0001127602-20-016619)

Filing Details

Accession Number:: 0001127602-20-016619
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-14 17:00:07
Reporting Period:: 2020-05-12

Accepted Time:: 2020-05-14 17:00:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1682852	Moderna Inc.	MRNA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1643746	H. Lorence Kim	C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-12	11,643	$12.21	1,234,153	No	4	M	Direct
Common Stock	Acquisiton	2020-05-12	229,357	$10.90	1,463,510	No	4	M	Direct
Common Stock	Disposition	2020-05-12	35,182	$62.56	1,428,328	No	4	S	Direct
Common Stock	Disposition	2020-05-12	31,948	$63.57	1,396,380	No	4	S	Direct
Common Stock	Disposition	2020-05-12	104,544	$64.67	1,291,836	No	4	S	Direct
Common Stock	Disposition	2020-05-12	61,412	$65.47	1,230,424	No	4	S	Direct
Common Stock	Disposition	2020-05-12	5,677	$66.43	1,224,747	No	4	S	Direct
Common Stock	Disposition	2020-05-12	2,237	$67.32	1,222,510	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-12	229,357	$0.00	229,357	$10.90
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-12	11,643	$0.00	11,643	$12.21

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-02-23	No	4	M	Direct
286,522		2027-02-23	No	4	M	Direct

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.04 to $63.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.07 to $64.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.09 to $65.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.10 to $66.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.12 to $66.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.16 to $67.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
This option is fully vested and exercisable.
25% of this option vested and became exercisable on February 22, 2018, with the remainder vesting in 12 equal quarterly installments thereafter.